What is Bevacizumab?

Category: Prescription Drugs

Most popular types: Avastin

false

Bevacizumab is a monoclonal antibody and vascular endothelial growth factor inhibitor used for various types of cancer. It has also been used for recurrent ovarian cancer and age-related macular degeneration.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Macular degeneration 8 3
Ovarian cancer 5 3
Adenocarcinoma (non-small cell lung cancer) 3 3
Colon cancer 3 1
Glioblastoma 3 3
Astrocytoma 2 2

Show all 18 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
5
Moderate
3
Mild
4
None
7

Commonly reported side effects and conditions associated with Bevacizumab

Side effect Patients
Allergic rhinitis 1
Anorexia nervosa 1
Body hair loss 1
Cervical radiculopathy 1
Dry mouth at night 1
Emotional distress 1

Show all 19 reported side effects

Dosages

Based on patients currently taking Bevacizumab

Dosage Patients
1 mg monthly 1
10 mg every 12 weeks 1
25 mg every 6 weeks 1
25 mg every 3 weeks 1
25 mg every other week 1

Why patients stopped taking Bevacizumab

Multiple reasons could be selected

Reason Patients
Doctor's advice 5
Course of treatment ended 4
Other 4
Side effects too severe 4
Did not seem to work 1
Expense 1
Personal research 1
See all 14 patients who've stopped taking Bevacizumab

Duration

Currently taking Bevacizumab

Duration Patients
1 - 2 years 2
2 - 5 years 1
5 - 10 years 2

Stopped taking Bevacizumab

Duration Patients
Less than 1 month 2
1 - 6 months 5
6 months - 1 year 4
1 - 2 years 1
2 - 5 years 2
Adherence
Adherence Evaluations
Always 13
Usually 1
Sometimes 2
Never taken as prescribed 3
Burden
Burden Evaluations
Very hard to take 4
Somewhat hard to take 7
A little hard to take 4
Not at all hard to take 4
Cost per month
Cost per month Evaluations
$200+ 3
$100-199 0
$50-99 0
$25-49 1
< $25 1
Not specified 14

What people switch to and from

Patients started taking Bevacizumab after stopping:

Treatment Patients
Carboplatin 2
Chemotherapy 1
Gemcitabine (Gemzar) 1
Paclitaxel (Taxol) 1

Patients stopped taking Bevacizumab and switched to:

Treatment Patients
Aflibercept (Eylea) 1
Nivolumab (Opdivo) 1
Last updated:

1 patient evaluation for Bevacizumab

Mar 19, 2013 (Started Aug 23, 2012)

  • Effectiveness
    Can't tell (for glioblastoma)
  • Side effects
    Moderate (swollen tongue, rash or skin problems, sore tongue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 25 mg Every Other Week
Advice & Tips: I got a skin abrassion feeling on 3 spots. The only problematic one was my tongue which felt as though someone took a nail file to it. This is a big reason for the pause in Avastin. I want to see it it changes anything there.

Feb 19, 2013 (Started Aug 23, 2012)

  • Effectiveness
    Slight (for glioblastoma)
  • Side effects
    Moderate (swollen tongue, rash or skin problems, sore tongue)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 25 mg Every Other Week

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Bevacizumab